← Back to Vaccine Database

ARCT-165 mRNA Vaccine

RNA based vaccine · VDDBV0093

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05037097 Phase 2COVID-19